Armida D’Incecco

2.7k total citations · 2 hit papers
34 papers, 2.1k citations indexed

About

Armida D’Incecco is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Armida D’Incecco has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Armida D’Incecco's work include Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Armida D’Incecco is often cited by papers focused on Lung Cancer Treatments and Mutations (21 papers), Lung Cancer Research Studies (13 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Armida D’Incecco collaborates with scholars based in Italy, United States and Netherlands. Armida D’Incecco's co-authors include Federico Cappuzzo, Gabriele Minuti, Carmelo Tibaldi, Lorenza Landi, M. E. Preobrazhenskaya, Natalia A. Ushakova, Licia Totani, Nikolay E. Nifantiev, Antônio Piccoli and Gabriel A. Rabinovich and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Armida D’Incecco

32 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds

2007 807 citations Albana Cumashi, Natalia A. Ushakova et al. Glycobiology profile →
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients

2014 492 citations Armida D’Incecco, Mariacarla Andreozzi et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armida D’Incecco Italy	16	825	714	713	479	252	34	2.1k
Karolina Okła Poland	15	323 0.4×	197 0.3×	45 0.1×	264 0.6×	67 0.3×	26	867
Ming‐De Yan Taiwan	20	136 0.2×	185 0.3×	59 0.1×	750 1.6×	293 1.2×	27	1.2k
Weijie Zhang China	19	426 0.5×	58 0.1×	107 0.2×	404 0.8×	143 0.6×	48	1.2k
Gunhild von Amsberg Germany	22	309 0.4×	101 0.1×	286 0.4×	480 1.0×	277 1.1×	115	1.5k
Amy Roshak United States	24	658 0.8×	37 0.1×	405 0.6×	1.2k 2.4×	444 1.8×	41	2.3k
Xiaoming Xu China	17	199 0.2×	60 0.1×	134 0.2×	530 1.1×	297 1.2×	49	1.0k
Pei-Chun Shen Taiwan	13	214 0.3×	37 0.1×	130 0.2×	536 1.1×	277 1.1×	20	895
Yun Fan China	21	890 1.1×	22 0.0×	610 0.9×	523 1.1×	140 0.6×	102	1.5k
Yunlong Wang China	19	79 0.1×	39 0.1×	68 0.1×	630 1.3×	244 1.0×	61	1.1k
Ok‐Hee Lee South Korea	15	154 0.2×	49 0.1×	40 0.1×	629 1.3×	351 1.4×	60	1.2k

Countries citing papers authored by Armida D’Incecco

Since Specialization

Citations

This map shows the geographic impact of Armida D’Incecco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armida D’Incecco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armida D’Incecco more than expected).

Fields of papers citing papers by Armida D’Incecco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armida D’Incecco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armida D’Incecco. The network helps show where Armida D’Incecco may publish in the future.

Co-authorship network of co-authors of Armida D’Incecco

This figure shows the co-authorship network connecting the top 25 collaborators of Armida D’Incecco. A scholar is included among the top collaborators of Armida D’Incecco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armida D’Incecco. Armida D’Incecco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Lingxiao, Chen Zhao, Xinye Zhang, et al.. (2024). MS4A15 gene expression as a prognostic marker for clinical outcomes in lung adenocarcinoma. Translational Lung Cancer Research. 14(1). 224–238.

Landi, Lorenza, Armida D’Incecco, Amanda Tufman, et al.. (2023). 2022P ALBA project: Prognostic impact of laterality in small cell lung cancer. Annals of Oncology. 34. S1074–S1074.

Colella, Sara, Roberta Marra, Stefano Marinari, et al.. (2022). Chest wall reconstruction in benign and malignant tumors with non-rigid materials: An overview. Frontiers in Surgery. 9. 976463–976463. 10 indexed citations

He, Zhen, Chenghui Zhang, Yunfang Chen, et al.. (2022). Efficacy and safety of anlotinib combined with carboplatin and pemetrexed as first-line induction therapy followed by anlotinib plus pemetrexed as maintenance therapy in EGFR/ALK wild-type advanced non-squamous non-small cell lung cancer in China: a multicenter, single-arm trial. Translational Lung Cancer Research. 11(8). 1657–1666. 4 indexed citations

Calabrò, Luana, Aldo Morra, Diana Giannarelli, et al.. (2018). Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study. The Lancet Respiratory Medicine. 6(6). 451–460. 152 indexed citations

Calabrò, Luana, Giovanni Luca Ceresoli, Armida D’Incecco, et al.. (2017). Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences. Cytokine & Growth Factor Reviews. 36. 25–31. 7 indexed citations

D’Incecco, Armida, Marianna Gallo, Antonella De Luca, et al.. (2017). Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC). Annals of Oncology. 28. vi62–vi62. 1 indexed citations

Minuti, Gabriele, Armida D’Incecco, & Federico Cappuzzo. (2015). Current and Emerging Options in the Management of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: Considerations in the Elderly. Drugs & Aging. 32(11). 907–916. 3 indexed citations

D’Arcangelo, M., Matilde Todaro, Jessica Salvini, et al.. (2015). Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. PLoS ONE. 10(5). e0125037–e0125037. 13 indexed citations

10.

D’Incecco, Armida, Mariacarla Andreozzi, Vienna Ludovini, et al.. (2014). PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients. British Journal of Cancer. 112(1). 95–102. 492 indexed citations breakdown →

11.

Minuti, Gabriele, Armida D’Incecco, Lorenza Landi, & Federico Cappuzzo. (2014). Protein kinase inhibitors to treat non-small-cell lung cancer. Expert Opinion on Pharmacotherapy. 15(9). 1203–1213. 17 indexed citations

12.

Minuti, Gabriele, Armida D’Incecco, & Federico Cappuzzo. (2013). Targeted therapy for NSCLC with driver mutations. Expert Opinion on Biological Therapy. 13(10). 1401–1412. 38 indexed citations

13.

Cappuzzo, Federico, Andrea Sacconi, Lorenza Landi, et al.. (2013). MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies. Clinical Colorectal Cancer. 13(1). 37–45.e4. 45 indexed citations

14.

Capodanno, Alessandra, Laura Boldrini, Agnese Proietti, et al.. (2013). Let-7g and miR-21 expression in non-small cell lung cancer: Correlation with clinicopathological and molecular features. International Journal of Oncology. 43(3). 765–774. 47 indexed citations

15.

Landi, Lorenza, Gabriele Minuti, Armida D’Incecco, & Federico Cappuzzo. (2013). Targeting c-MET in the battle against advanced nonsmall-cell lung cancer. Current Opinion in Oncology. 25(2). 130–136. 29 indexed citations

16.

Tibaldi, Carmelo, Elisa Giovannetti, Marcello Tiseo, et al.. (2011). Correlation of cytidine deaminase polymorphisms and activity with clinical outcome in gemcitabine-/platinum-treated advanced non-small-cell lung cancer patients. Annals of Oncology. 23(3). 670–677. 45 indexed citations

17.

Lemos, Clara, Elisa Giovannetti, Paolo Andrea Zucali, et al.. (2011). Impact of ABCG2 Polymorphisms on the Clinical Outcome and Toxicity of Gefitinib in Non-Small-Cell Lung Cancer Patients. Pharmacogenomics. 12(2). 159–170. 53 indexed citations

18.

Maio, Ermelinda De, Carmelo Tibaldi, Armida D’Incecco, et al.. (2010). Consequences of targeted treatments for second-line therapy. Annals of Oncology. 21. vii234–vii240. 4 indexed citations

19.

Tibaldi, Carmelo, et al.. (2009). Cisplatin plus Gemcitabine as Adjuvant Chemotherapy for Radically Resected Non–Small-Cell Lung Cancer: A Pilot Study. Clinical Lung Cancer. 10(1). 53–57. 13 indexed citations

20.

Cumashi, Albana, Natalia A. Ushakova, M. E. Preobrazhenskaya, et al.. (2007). A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 17(5). 541–552. 807 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact